Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.69
0.00 (0.00%)
At close: Sep 15, 2026, 4:00 PM EDT
6.70
+0.01 (0.15%)
After-hours: Sep 15, 2026, 7:30 PM EDT
Gyre Therapeutics Employees
Gyre Therapeutics had 625 employees as of December 31, 2025. The number of employees increased by 46 or 7.94% compared to the previous year.
Employees
625
Change (1Y)
46
Growth (1Y)
7.94%
Revenue / Employee
$175,709
Profits / Employee
-$31,853
Market Cap
709.37M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 625 | 46 | 7.94% |
| Dec 31, 2024 | 579 | -14 | -2.36% |
| Dec 31, 2023 | 593 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 4D Molecular Therapeutics | 196 |
| MapLight Therapeutics | 133 |
| Neurogene | 131 |
| DBV Technologies | 126 |
| Aura Biosciences | 113 |
| Annexon | 92 |
| CytomX Therapeutics | 69 |
| Zevra Therapeutics | 61 |
GYRE News
- 12 days ago - Gyre Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 14 days ago - Gyre Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - Gyre Therapeutics Earnings release: Q2 2026 - Filings
- 5 weeks ago - Gyre Therapeutics Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Gyre Therapeutics Appoints Three New Members to its Board of Directors - GlobeNewsWire
- 2 months ago - Gyre Therapeutics Registration statement: Registration filing - Filings
- 2 months ago - Gyre Therapeutics Registration statement: Registration filing - Filings